Aimmune Therapeutics, Inc.: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2019)
- -$248.5M
- Total Assets (FY2019)
- $204.4M
- Total Equity (FY2019)
- $104.0M
- Cash Flows from Operating Activities (FY2019)
- -$195.4M
Source: Aimmune Therapeutics, Inc. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
